Milena Keremidarska-Markova

Dr. Milena Keremidarska-Markova

Faculty of Biology, Animal and Human Physiology, Sofia University, Sofia, Sofia-Grad, Bulgaria
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
MMMitko Mladenov
Mitko Mladenov
LLLubomir Lubomirov
Lubomir Lubomirov
OGOlaf Grisk
Olaf Grisk
Dimiter AvtanskiDimiter Avtanski
Dimiter Avtanski
VMVadim Mitrokhin
Vadim Mitrokhin
HGHristo Gagov
Hristo Gagov
This review is focused on the mechanisms that regulate health, disease and aging redox status, the signal pathways that counteract oxidative and reductive stress, the role of food components and additives with antioxidant properties (curcumin, polyphenols, vitamins, carotenoids, flavonoids, etc.), and the role of the hormones irisin and melatonin in the redox homeostasis of animal and human cells. The correlations between the deviation from optimal redox conditions and inflammation, allergic, aging and autoimmune responses are discussed. Special attention is given to the vascular system, kidney, liver and brain oxidative stress processes. The role of hydrogen peroxide as an intracellular and paracrine signal molecule is also reviewed. The cyanotoxins β-N-methylamino-l-alanine (BMAA), cylindrospermopsin, microcystins and nodularins are introduced as potentially dangerous food and environment pro-oxidants.

20 March 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
NKNatalia Krasteva
Natalia Krasteva
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
Kamelia Hristova-PanushevaKamelia Hristova-Panusheva
Kamelia Hristova-Panusheva
TATonya Andreeva
Tonya Andreeva
Giorgio SperanzaGiorgio Speranza
Giorgio Speranza
Milena GeorgievaMilena Georgieva
Milena Georgieva
Nanotechnology-based drug delivery systems for cancer therapy are the topic of interest for many researchers and scientists. Graphene oxide (GO) and its derivates are among the most extensively studied delivery systems of this type. The increased surface area, elevated loading capacity, and aptitude for surface functionalization together with the ability to induce reactive oxygen species make GO a promising tool for the development of novel anticancer therapies. Moreover, GO nanoparticles not only function as effective drug carriers but also have the potential to exert their own inhibitory effects on tumour cells. Recent results show that the functionalization of GO with different functional groups, namely, with amine groups, leads to increased reactivity of the nanoparticles. The last steers different hypotheses for the mechanisms through which this functionalization of GO could potentially lead to improved anticancer capacity. In this research, we have evaluated the potential of amine-functionalized graphene oxide nanoparticles (GO-NH2) as new molecules for colorectal cancer therapy. For the purpose, we have assessed the impact of aminated graphene oxide (GO) sheets on the viability of colon cancer cells, their potential to generate ROS, and their potential to influence cellular proliferation and survival. In order to elucidate their mechanism of action on the cellular systems, we have probed their genotoxic and cytostatic properties and compared them to pristine GO. Our results revealed that both GO samples (pristine and aminated) were composed of few-layer sheets with different particle sizes, zeta potential, and surface characteristics. Furthermore, we have detected increased cyto- and genotoxicity of the aminated GO nanoparticles following 24-hour exposure on Colon 26 cells. The last leads us to conclude that exposure of cancer cells to GO, namely, aminated GO, can significantly contribute to cancer cell killing by enhancing the cytotoxicity effect exerted through the induction of ROS, subsequent DNA damage, and apoptosis.

4 July 2014 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
AGAneliya Ganeva
Aneliya Ganeva
DMDimitar Mitev
Dimitar Mitev
THTodor Hikov
Todor Hikov
RPRadina Presker
Radina Presker
NKNatalia Krasteva
Natalia Krasteva
Recently, nanodiamonds (NDs) have attracted great interest due to their unique physical and chemical properties that could be used in various biological applications. However, depending on the origin, NDs often contain different impurities which may affect cellular functions and viability. Therefore, before their biomedical application, the cytotoxicity of newly produced NDs should be assessed. In the present study, we have evaluated cytotoxicity of four types of ND particles with two cell models: a human osteosarcoma cell line, MG-63, and primary rat mesenchymal stem cells (rMSCs). Detonation-generated nanodiamond (DND) particles were purified with different acid oxidizers and impurities’ content was determined by elemental analysis. The particles size distribution was measured revealing that the DND particles have an average size in the range of 51–233 nm. Cytotoxicity was assessed by optical microscopy and proliferation assay after 72 hours exposure of the cells to nanoparticles. We observed cell-specific and material-specific toxicity for all tested particles. Primary stem cells demonstrated higher sensitivity to DND particles than osteosarcoma cells. The most toxic were the DND particles with the smallest grain size and slight content of non-diamond carbon, while DNDs with higher grain size and free from impurities had no significant influence on cell proliferation and morphology. In addition, the smaller DND particles were found to form large aggregates mainly during incubation with rMSCs. These results demonstrate the role of the purification method on the properties of DND particles and their cytotoxicity as well as the importance of cell types used for evaluation of the nanomaterials.

20 November 2023 in Cancers
Verified
Journal Article
Open access
PDF file
ISIliyana Sazdova
Iliyana Sazdova
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
DDDaniela Zdravkova Dimitrova
Daniela Zdravkova Dimitrova
VMVadim Mitrokhin
Vadim Mitrokhin
AKAndre Kamkin
Andre Kamkin
MMMitko Mladenov
Mitko Mladenov
EF24, a synthetic monocarbonyl analog of curcumin, shows significant potential as an anticancer agent with both chemopreventive and chemotherapeutic properties. It exhibits rapid absorption, extensive tissue distribution, and efficient metabolism, ensuring optimal bioavailability and sustained exposure of the target tissues. The ability of EF24 to penetrate biological barriers and accumulate at tumor sites makes it advantageous for effective cancer treatment. Studies have demonstrated EF24’s remarkable efficacy against various cancers, including breast, lung, prostate, colon, and pancreatic cancer. The unique mechanism of action of EF24 involves modulation of the nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathways, disrupting cancer-promoting inflammation and oxidative stress. EF24 inhibits tumor growth by inducing cell cycle arrest and apoptosis, mainly through inhibiting the NF-κB pathway and by regulating key genes by modulating microRNA (miRNA) expression or the proteasomal pathway. In summary, EF24 is a promising anticancer compound with a unique mechanism of action that makes it effective against various cancers. Its ability to enhance the effects of conventional therapies, coupled with improvements in drug delivery systems, could make it a valuable asset in cancer treatment. However, addressing its solubility and stability challenges will be crucial for its successful clinical application.

23 December 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
ISIliyana Sazdova
Iliyana Sazdova
MMMitko Mladenov
Mitko Mladenov
Bissera PilichevaBissera Pilicheva
Bissera Pilicheva
PZPlamen Zagorchev
Plamen Zagorchev
HGHristo Gagov
Hristo Gagov
Aging affects the structure and functions of all organs and systems in the organism. In the elderly, significant changes in hormonal levels are observed. These translate to a predisposition for chronic diseases, including cardiovascular, neurodegenerative, and metabolic disorders. Therefore, tremendous scientific effort is focused on investigating molecular mechanisms and drugs with the potential to reduce hormonal changes in old age and their impact. Sirtuin 1 (SIRT1), a member of the sirtuin family of deacetylases, has been extensively studied as a regulator of multiple pathways related to antioxidant properties, optimal immune response, and metabolism. SIRT1 plays a key role in regulating various hormonal pathways and maintaining homeostasis. In the present study, we review the interplay between SIRT1 and hormonal regulations, including the endocrine role of the hypothalamic–pituitary–thyroid, –adrenal, –gonadal, and –liver axes, of other endocrine glands, and of non-endocrine tissues in the aging organism. The application of natural SIRT1 activators, such as resveratrol, curcumin, paeonol, and Buyang Huanwu Decoction, for the treatment of aging and senescence is discussed. SIRT1 activators improve mitochondrial function, reduce oxidative stress, and promote longevity, but their clinical application is limited by low bioavailability and poor permeability across biological barriers. For this reason, advanced delivery strategies are being considered, including nose-to-brain drug delivery and nanotechnology-based formulations.

11 March 2017 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
DGDencho Gugutkov
Dencho Gugutkov
FAFiras Awaja
Firas Awaja
KBKalina Belemezova
Kalina Belemezova
Milena Keremidarska-MarkovaMilena Keremidarska-Markova
Milena Keremidarska-Markova
NKNatalia Krasteva
Natalia Krasteva
GAGeorge Altankov
George Altankov